Glenmark Pharmaceuticals Ltd

Glenmark Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Glenmark Pharmaceuticals Ltd

₹ 1,858 0.98%
20 Nov 12:34 p.m.
glenmarkpharma.com BSE: 532296 NSE: GLENMARK
About

Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries.[1]

Key Points

Leadership[1]

<h1>14th largest and fastest growing in the Indian market</h1> <h1>15th largest generic company by prescriptions filled in the USA</h1> <h1>5th largest Indian generic co. in Europe.</h1>
Website BSE NSE
  • Market Cap ₹ 52,439 Cr.
  • Current Price ₹ 1,858
  • High / Low ₹ 2,286 / 1,275
  • Stock P/E 20.8
  • Book Value ₹ 340
  • Dividend Yield 0.14 %
  • ROCE 19.4 %
  • ROE 15.8 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • The company has delivered a poor sales growth of 4.60% over past five years.
  • Company has a low return on equity of -10.1% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare Nifty 500 BSE MidCap Nifty Pharma

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
3,018 3,100 3,001 3,036 3,207 2,507 3,063 3,244 3,434 3,388 3,256 3,264 6,047
2,539 2,626 2,603 2,599 2,745 2,715 2,559 2,656 2,832 2,787 2,695 2,684 3,687
Operating Profit 479 474 398 437 462 -209 504 588 602 600 561 581 2,360
OPM % 16% 15% 13% 14% 14% -8% 16% 18% 18% 18% 17% 18% 39%
86 209 -696 -32 -205 87 351 31 39 31 -361 -297 -1,184
Interest 83 97 109 112 121 134 149 40 48 52 67 58 66
Depreciation 146 152 135 142 141 147 151 118 120 123 125 130 141
Profit before tax 337 435 -542 151 -6 -403 555 462 473 456 8 96 967
Tax % 17% 33% -26% -14% 997% -18% 319% 26% 25% 24% 45% 51% 37%
279 291 -403 173 -62 -331 -1,214 340 354 348 4 47 610
EPS in Rs 9.23 9.66 -15.18 5.31 -2.90 -12.45 -43.17 12.06 12.55 12.33 0.16 1.66 21.63
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
6,005 6,563 7,562 9,079 9,074 9,865 10,641 10,944 12,305 12,990 11,813 13,322 15,955
4,914 5,348 6,125 7,043 7,457 8,280 8,942 8,860 9,978 10,712 10,618 10,970 11,854
Operating Profit 1,091 1,214 1,437 2,037 1,617 1,586 1,699 2,084 2,327 2,278 1,195 2,351 4,101
OPM % 18% 18% 19% 22% 18% 16% 16% 19% 19% 18% 10% 18% 26%
11 -180 20 -44 89 375 191 95 -101 -449 336 -259 -1,811
Interest 189 190 179 237 286 335 377 353 298 350 516 207 244
Depreciation 217 300 234 264 302 326 417 444 487 611 582 486 519
Profit before tax 697 544 1,044 1,491 1,119 1,301 1,096 1,382 1,441 868 434 1,399 1,527
Tax % 22% 61% 29% 26% 28% 29% 29% 30% 31% 57% 430% 25%
546 209 743 1,109 804 925 776 970 994 377 -1,434 1,047 1,010
EPS in Rs 19.99 7.72 26.33 39.29 28.49 32.78 27.50 34.38 33.37 10.53 -53.22 37.11 35.78
Dividend Payout % 0% 26% 8% 5% 7% 6% 9% 7% 7% 24% -5% 7%
Compounded Sales Growth
10 Years: 7%
5 Years: 5%
3 Years: 3%
TTM: 30%
Compounded Profit Growth
10 Years: 17%
5 Years: 12%
3 Years: 6%
TTM: 227%
Stock Price CAGR
10 Years: 7%
5 Years: 31%
3 Years: 65%
1 Year: 23%
Return on Equity
10 Years: 6%
5 Years: -1%
3 Years: -10%
Last Year: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 27 27 28 28 28 28 28 28 28 28 28 28 28
Reserves 2,956 1,756 3,601 4,464 5,135 5,577 6,042 7,036 9,058 9,446 7,820 8,821 9,554
3,267 3,800 3,988 4,724 4,639 4,449 4,869 4,986 3,962 4,627 1,231 2,473 1,224
2,176 2,726 2,575 2,548 2,793 3,235 3,729 3,524 4,003 5,228 5,279 4,669 8,196
Total Liabilities 8,427 8,309 10,193 11,764 12,595 13,289 14,668 15,575 17,052 19,329 14,358 15,991 19,002
3,091 2,015 2,594 2,755 3,030 3,670 5,029 5,129 5,887 6,202 4,210 4,487 5,210
CWIP 5 477 543 708 1,122 1,399 1,222 1,382 1,010 1,251 662 835 695
Investments 0 17 17 16 15 30 25 25 50 45 790 56 42
5,331 5,799 7,039 8,285 8,429 8,190 8,393 9,040 10,105 11,830 8,697 10,613 13,054
Total Assets 8,427 8,309 10,193 11,764 12,595 13,289 14,668 15,575 17,052 19,329 14,358 15,991 19,002

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
854 482 345 657 1,648 1,324 1,392 1,131 1,109 625 -265 -828
-566 -712 -950 -1,001 -1,003 -883 -774 -662 -316 -515 4,387 58
-98 199 699 543 -468 -739 -445 -442 -520 -77 -3,906 787
Net Cash Flow 190 -31 93 199 177 -297 174 28 272 32 215 17

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 131 140 120 97 94 81 83 86 92 115 57 92
Inventory Days 191 247 249 299 244 244 211 230 212 240 208 254
Days Payable 279 379 308 243 225 241 210 226 194 192 210 216
Cash Conversion Cycle 43 8 61 152 113 85 84 90 110 162 56 129
Working Capital Days 62 47 51 125 99 64 54 67 65 94 -2 44
ROCE % 15% 16% 19% 21% 15% 15% 14% 15% 16% 14% 12% 19%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.64% 46.64%
23.19% 22.47% 25.51% 24.79% 23.71% 21.38% 20.98% 23.05% 23.51% 23.15% 20.62% 20.73%
10.69% 10.40% 9.10% 10.31% 10.92% 13.36% 13.93% 13.21% 13.85% 14.60% 17.64% 18.61%
0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
19.45% 20.46% 18.70% 18.21% 18.70% 18.58% 18.42% 17.06% 15.96% 15.56% 15.05% 13.97%
No. of Shareholders 3,00,1062,85,4612,36,9082,32,6852,09,9311,99,4511,92,6301,93,9491,95,0591,92,7241,90,2101,98,789

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls